Catalyst Calendar • Endpoint Arena

Catalyst Calendar

Fri, Jul 10, 2026

1 updates

11:23 AM

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

pfizer.com

Wed, Jun 24, 2026

2 updates

3:52 PM

Pfizer Declares Third-Quarter 2026 Dividend

pfizer.com

2:10 PM

FDA Approves Pfizer’s IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

pfizer.com

Tue, Jun 23, 2026

1 updates

10:00 AM

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

pfizer.com

Mon, Jun 22, 2026

1 updates

4:30 PM

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Trial Results • Phase 3pfizer.com

Thu, Jun 18, 2026

1 updates

6:45 AM

Pfizer Announces Chief Financial Officer Transition

pfizer.com

Mon, Jun 8, 2026

1 updates

6:45 AM

U.S. FDA Approves Pfizer’s HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

pfizer.com

Sat, Jun 6, 2026

1 updates

9:00 AM

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer’s GLP-1 RA Berobenatide

Trial Results • Phase 2pfizer.com

Mon, Jun 1, 2026

1 updates

10:00 AM

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

pfizer.com

Sun, May 31, 2026

1 updates

8:00 AM

Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

pfizer.com

Sat, May 30, 2026

1 updates

8:00 AM

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

Trial Results • Phase 3pfizer.com

Fri, May 29, 2026

1 updates

8:00 AM

Seven-Year Analysis from Pfizer’s LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

pfizer.com

Thu, May 28, 2026

1 updates

7:00 PM

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

pfizer.com

Wed, May 27, 2026

1 updates

10:00 AM

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

pfizer.com

Wed, May 20, 2026

1 updates

5:05 AM

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

pfizer.com

Wed, May 13, 2026

1 updates

6:45 AM

European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

pfizer.com

Tue, May 5, 2026

1 updates

6:45 AM

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

pfizer.com

Wed, Apr 29, 2026

1 updates

6:45 AM

Pfizer’s ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

pfizer.com

Tue, Apr 28, 2026

1 updates

10:17 AM

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

pfizer.com

Wed, Apr 22, 2026

1 updates

4:45 PM

Pfizer Declares Second-Quarter 2026 Dividend

pfizer.com

Tue, Apr 21, 2026

1 updates

11:51 AM

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

pfizer.com

Mon, Apr 20, 2026

1 updates

6:45 AM

U.S. FDA Grants Priority Review to sBLA for PADCEV + Keytruda as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

pfizer.com